Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	69
Overall Study	STARTED	Tapentadol 50mg Fixed Dose	275
Overall Study	STARTED	Tapentadol 75mg Fixed Dose	278
Overall Study	STARTED	Oxycodone 10mg Fixed Dose	279
Overall Study	COMPLETED	Placebo	49
Overall Study	COMPLETED	Tapentadol 50mg Fixed Dose	247
Overall Study	COMPLETED	Tapentadol 75mg Fixed Dose	255
Overall Study	COMPLETED	Oxycodone 10mg Fixed Dose	253
Overall Study	NOT COMPLETED	Placebo	20
Overall Study	NOT COMPLETED	Tapentadol 50mg Fixed Dose	28
Overall Study	NOT COMPLETED	Tapentadol 75mg Fixed Dose	23
Overall Study	NOT COMPLETED	Oxycodone 10mg Fixed Dose	26

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00613938/flow